Meridian Bioscience Inc. (VIVO)
$3.81
$-0.26
(-6.39%)
As on 01-Sep-2026 16:17EDT
Market cap
$125 Mln
Revenue (TTM)
$302 Mln
P/E Ratio
--
P/B Ratio
8
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-3 Mln
-
ROE
0 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-4.1
-
Debt to Equity
--
-
Book Value
$--
-
EPS
$-1.1
-
Face value
--
-
Shares outstanding
30,724,084
10 Years Aggregate
CFO
$471.90 Mln
EBITDA
$623.71 Mln
Net Profit
$370.38 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Meridian Bioscience (VIVO)
| -- | 6.7 | -38.9 | -- | -- | -28.4 | -15.0 |
|
BSE Sensex*
| -9.8 | -2.2 | 2.9 | -4.9 | 5.3 | 5.9 | 10.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
|---|---|---|---|---|---|---|---|
|
Meridian Bioscience (VIVO)
| 62.8 | 9.1 | 91.3 | -43.3 | 27.8 | -18.0 | -9.9 |
|
S&P Small-Cap 600
| -17.4 | 25.3 | 9.6 | 20.9 | -9.7 | 11.7 | 24.7 |
|
BSE Sensex
| 4.4 | 22.0 | 15.8 | 14.4 | 5.9 | 27.9 | 1.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Meridian Bioscience (VIVO)
|
3.8 | 124.7 | 0.0 | -46.7 | 2.1 | 253.9 | -- | 8.0 |
| 515.2 | 7,065.2 | 2,595.0 | 275.0 | 14.1 | 30.4 | 26.9 | 8.4 | |
| 122.1 | 11,869.0 | 6,206.1 | 621.0 | 18.6 | 16.2 | 20.2 | 4.6 | |
| 28.4 | 7,433.4 | 2,578.1 | -142.0 | -6.3 | -32.8 | -- | 22.4 | |
| 12.6 | 4,703.1 | 1,584.8 | 50.6 | 4.9 | 3.4 | 94.7 | 3.2 | |
| 219.0 | 3,707.8 | 1,559.0 | 140.3 | 12.1 | 12.6 | 26.3 | 3.3 | |
| 49.7 | 4,147.5 | 1,003.0 | -24.3 | 5.5 | -2.1 | 294.5 | 1.5 | |
| 75.5 | 5,871.6 | 2,268.9 | -21.1 | 4.7 | -4.5 | -- | 5.4 | |
| 18.7 | 5,499.2 | 1,216.2 | 163.5 | 33.5 | 25.7 | 33.8 | 8.4 | |
| 173.2 | 10,081.7 | 5,486.7 | 378.7 | 9.2 | 16.2 | 27.1 | 4.1 |
Shareholding Pattern
View DetailsAbout Meridian Bioscience (VIVO)
VivoPower PLC, together with its subsidiaries, provides energy solutions for customized and ruggedized fleet applications, battery and microgrids, and solar and critical power technology and services. It operates through Electric Vehicles,... Sustainable Energy Solutions, Solar Development, and Digital Assets segments. The Electric Vehicles segment offers ruggedized battery-powered Electric Vehicle (EV) solutions, including conversion kits for fleet owners in the mining, agriculture, energy utility, defense, police, government, public transport, humanitarian, and game safari industries. It also offers ruggedized or customized on-road applications; public utility vehicle electric powertrain conversion kits for the jeepneys; and OEM light utility pickup trucks under the Tembo Tuskers brand name, as well as EV charging solutions for home and commercial applications. The Sustainable Energy Solutions segment engages in the design, evaluation, sale, and implementation of renewable energy infrastructure. The Solar Development segment develops solar projects. The Digital Assets segment engages in digital asset mining activities. It operates in Australia, Canada, the Netherlands, the United Kingdom, the United States, the United Arab Emirates, and the Philippines. The company was formerly known as VivoPower International PLC and changed its name to VivoPower PLC in March 2026. VivoPower PLC was founded in 2014 and is headquartered in London, the United Kingdom. Read more
-
Pres, CEO & Director
Mr. John P. Kenny
-
Pres, CEO & Director
Mr. John P. Kenny
-
Headquarters
London
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Meridian Bioscience (VIVO)
What is the current share price of Meridian Bioscience Inc (VIVO) Today?
The share price of Meridian Bioscience Inc (VIVO) is $3.81 (NASDAQ) as of 01-Sep-2026 16:17 EDT. Meridian Bioscience Inc (VIVO) has given a return of --% in the last 1 years.
What is the current PB & PE ratio of Meridian Bioscience Inc (VIVO)?
Since, TTM earnings of Meridian Bioscience Inc (VIVO) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2024 |
-- |
-- |
2023 |
-- |
-- |
2022 |
32.67 |
3.77 |
2022 |
-60.69 |
61.92 |
2021 |
11.86 |
2.58 |
What is the 52 Week High and Low of Meridian Bioscience Inc (VIVO)?
The 52-week high and low of Meridian Bioscience Inc (VIVO) are Rs 6.86 and Rs 2.08 as of 02-Sep-2026.
What is the market cap of Meridian Bioscience Inc (VIVO)?
Meridian Bioscience Inc (VIVO) has a market capitalisation of $ 125 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Meridian Bioscience Inc (VIVO)?
Before investing in Meridian Bioscience Inc (VIVO), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.